OTCMKTS:MHIVF - Invesque Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $2.75
  • Forecasted Upside: -13.25 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.17
▲ +0.18 (6.02%)
1 month | 3 months | 12 months
Get New Invesque Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MHIVF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MHIVF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$2.75
▼ -13.25% Downside Potential
This price target is based on 2 analysts offering 12 month price targets for Invesque in the last 3 months. The average price target is $2.75, with a high forecast of $3.00 and a low forecast of $2.50. The average price target represents a -13.25% upside from the last price of $3.17.
Hold
The current consensus among 2 polled investment analysts is to hold stock in Invesque.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
4/1/2021BMO Capital MarketsReiterated RatingOutperform ➝ Market Perform$2.75 ➝ $2.50
i
3/26/2021BMO Capital MarketsDowngradeOutperform ➝ Market Perform$2.75 ➝ $2.50
i
5/15/2020Canaccord GenuityReiterated RatingHold$3.00
i
3/16/2020CIBCDowngradeHold$5.50
i
Rating by Chris Couprie at CIBC
(Data available from 4/19/2016 forward)
Invesque logo
Invesque Inc. operates as a real estate investment company in Canada and the United States. Its portfolio of investments include independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 11, 2021, it owned a portfolio of 107 properties, including 72 assisted living and memory care facilities, 17 skilled nursing facilities, 13 transitional care properties, and 4 medical office buildings in the United States; and 15 properties comprised 11 medical office buildings, and 4 seniors housing and care facilities in Canada. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. is headquartered in Toronto, Canada.
Read More

Today's Range

Now: $3.17
$3.15
$3.23

50 Day Range

MA: $2.70
$2.32
$3.21

52 Week Range

Now: $3.17
$1.48
$3.59

Volume

10,687 shs

Average Volume

18,416 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Invesque?

The following Wall Street research analysts have issued reports on Invesque in the last year: BMO Capital Markets, and Canaccord Genuity.
View the latest analyst ratings for MHIVF.

What is the current price target for Invesque?

2 Wall Street analysts have set twelve-month price targets for Invesque in the last year. Their average twelve-month price target is $2.75, suggesting a possible downside of 13.2%. Canaccord Genuity has the highest price target set, predicting MHIVF will reach $3.00 in the next twelve months. BMO Capital Markets has the lowest price target set, forecasting a price of $2.50 for Invesque in the next year.
View the latest price targets for MHIVF.

What is the current consensus analyst rating for Invesque?

Invesque currently has 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MHIVF, but not buy more shares or sell existing shares.
View the latest ratings for MHIVF.

How do I contact Invesque's investor relations team?

The company's listed phone number is 317-643-4017. The official website for Invesque is invesque.com.